| 000 | 01336 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514232230.0 | ||
| 264 | 0 | _c20050804 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a1088-0224 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSullivan, Patrick W | |
| 245 | 0 | 0 |
_aThe effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. _h[electronic resource] |
| 260 |
_bThe American journal of managed care _cJun 2005 |
||
| 300 |
_a374-82 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCalifornia |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 |
_aDrug Utilization Review _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance, Pharmaceutical Services _xeconomics |
| 650 | 0 | 4 |
_aLoratadine _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNonprescription Drugs |
| 650 | 0 | 4 |
_aRhinitis, Allergic, Perennial _xdrug therapy |
| 700 | 1 | _aNair, Kavita V | |
| 700 | 1 | _aPatel, Bimal V | |
| 773 | 0 |
_tThe American journal of managed care _gvol. 11 _gno. 6 _gp. 374-82 |
|
| 999 |
_c15632470 _d15632470 |
||